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Introduction: Bone marrow aspiration (BMA) and bone marrow biopsy (BMB) is an indispensable diag-
nostic tool for evaluating haematological and non-haematological disorders and patient follow-up in pre-
sent era. We have compared the advantages of trephine biopsy over bone marrow aspiration in these
patients.
Aim and objective: To evaluate sensitivity and specificity of trephine biopsy test for haematological and
non haematological disorder patients in comparison to bone marrow aspiration test.
Materials and method: In this 1 year prospective study (June 2014–May 2015), we evaluated the haema-
tological and non-haematological disorder patients by BMA and BMB (aided with I.H.C. when ever
needed). The sensitivity and specificity of the tests were calculated.
Results: Among, final 504 hemotological/non haematological disorder patients, 416 cases were diagnosed
(+ve) in BMA test, where as it was 494 in BMB test and with chi2 test it was highly significant as
p = 0.0001. It was concluded that True positive cases were 416, True negative were 9 cases, false negative
78 cases and false positive was in one case only. The sensitivity and specificity of bone marrow trephine
biopsy test was 84% and 90% respectively.
Conclusion: BMB (aided with I.H.C) is a gold standard test for detecting different haematological and non
hamatological disorders. In our study the sensitivity and specificity of BMB test was 84% and 90% respec-
tively. When performed in association with BMA in the same sitting, significantly augments the chances
of reaching a correct diagnosis.
 2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bone marrow examination includes pathological examination
of bone marrow aspiration (BMA) and bone marrow biopsy
(BMB) specimens. Peripheral blood gives much of information
regarding haematological disorders but many a times, ‘‘the assess-
ment of haematopoesis with BMA and BMB” are highly required.
BMA and BMB are an invaluable diagnostic tool for both haemato-
logical and non-haematological disorders. It is also routinely used
for follow up of patients undergoing chemotherapy for hema-
tolymphoid malignancies.1 Marrow samples can be obtained from
various sites. BMA and trephine BMB are commonly done from
posterior superior iliac spine and iliac crest. BMA can be done fromsternum with patient lying on his back, and pillow under the
shoulder. Ideally it should not be done from sternum, because of
risk of damaging vital organs. BMA can also be done from tibia in
children up to 2 years of age.
BMA is the best tool for studying morphology, differential count
and M:E ratio. It can be used for flowcytometry, cytogenetics as
well as procedures like Polymerase chain reaction. whereas tre-
phine BMB gives information regarding cellularity, architecture
and focal lesions. Moreover, trephine biopsy is mandatory for stag-
ing of lymphomas.2 Rarely marrow examination provides the only
clue regarding occult malignancies.3
BMB is not only the ‘clue’ for infiltration, but also provides pat-
tern of involvement.4 In earlier days surgical trephine biopsy was
in practice. With introduction of needle trephine biopsy in late
1950s, things have become much simpler and minimally invasive.4
However, trephine biopsy, unlike aspiration, demands more tech-
nical skills and is time consuming as well as a painful procedure.
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section and availability of ancillary techniques like immunohisto-
chemistry, special staining and good coordination between
hematopathologists and histopathologists.5 Bone marrow proce-
dures help in confirming the clinical diagnosis as well as some
new diagnosis, which were not suspected previously. Few studies
have analyzed the diagnostic accuracy of marrow aspirates with
trephine biopsies.1,6–8 Here, we compare these two tests i.e. BMB
and BMA, to evaluate the sensitivity and specificity of BMB in
haematological and non-haematological patients in the same
sitting.2. Material and methods
This single centre prospective study was carried out, by the
Department of Pathology (Lab Hematology), Department of
Hemato-oncology and Stem cell transplantation, Medicine and
Paediatrics in IMS & SUM Hospital from June 2014 to May 2015.
This study was done for bone marrow examination on patients
presenting with anemia, history of thrombocytopenia, leukopenia,
pancytopenia, marked leucocytosis, bleeding/disseminated
intravascular coagulation, fever and organomegaly. Both indoor
and outdoor patients, showing features, raising suspicion of
involvement of bone marrow by non haematological/haematolog-
ical disorders were included. Relevant history, informed consent
and other bio-datas were noted. Patients were investigated for rou-
tine complete blood count (CBC), peripheral blood smear comment
(PSC), reticulocyte count, coagulation profile (prothrombin time,
activated partial thromboplastin time, thrombin time, fibrinogen).
Then BMA and trephine BMB were done for these patients at the
same sitting. A total of 595 (570 + 25) cases of BMA along with tre-
phine BMB were carried out. Out of which 25 tests were inade-
quate for assessment, hence excluded from the study. Adequacy
of biopsy was based on the presence of at least 5–6 intertrabecular
spaces. So the cohort comprised of 570 cases. Among them 66
cases were post induction marrows for assessment of remission.
So, these 66 cases were excluded from this study. Finally, for com-
parison of trephine BMB with BMA tests a total of 504 cases were
studied.
The clinical indications, physical findings and peripheral smear
findings of patients were compiled. Under local anesthesia (2%
xylocaine, 2% lignocaine) infiltration of periosteal region, the
BMA and BMB were done from posterior superior iliac spine, by
using jamshidi needle. Patient is made to lie on their side (lat-
eral decubitus position). A Bone marrow aspiration needle was
inserted through the skin with pressure until it abuts the bone.
The needle was advanced through the bony cortex and in the mar-
row cavity with twisting motion of the hand and wrist of the clin-
ician. After the needle tip reaches the marrow cavity, a syringe was
attached to the back of the jamshidi needle and aspiration done. A
twisting motion is performed during the aspiration to avoid excess
content of blood in the sample. For BMA procedure, Jamshidi nee-
dle (13 G for children, 11 G for adults) and Illinois needle size 18
were used. Subsequently 0.25–0.5 ml aspirate was withdrawn
using a 2 ml plastic syringe and smears were prepared immedi-
ately. Trephine BMB was done using Jamshidi biopsy needle and
at the same incision but approximately 0.5–1.0 cm away from aspi-
ration site to avoid getting a haemorrhagic biopsy. In patients of
thrombocytopenia, 5 minof firm pressure was applied at the end
of the procedure. At the same time patients were asked to lie down
on their back for further 10–15 min for prolonged pressure. Aspira-
tion smears were stained with Giemsa stain after being fixed in
alcohol. Prussion blue stain for iron store assessment and grading
was done routinely. Biopsy specimen was fixed using 10% buffered
formalin and decalcified using 10% formic acid for 24 h andprocessed by preparing paraffin wax embedding sections. Histo-
logical sections were made approximately 1–2 mm thick. Haema-
toxylin and eosin (H&E) stain was used and reticulin fibres were
stained with Gomori’s silver impregnation method routinely.
Immuno histo chemistry (IHC) was done as and when required.3. Results
Both BMA and trephine BMB tests were performed on all 504
cases of haematological and non-haematological patients. In
BMA, 416 cases were diagnosed (positive) whereas in trephine
BMB, it was 494 cases (Table 1). The chi-square statistic is
68.7673 and p-value is 0.0001. This result is significant at p  0.05.
The 504 new cases were divided into 3 age group categories. 4
cases were below 1 yrs of age, 91 cases belonged to 1–14 yrs age
group and 410 cases were above 14 yrs of age (Fig. 1). The cases
were divided into groups according to the final diagnosis, after
assessing the peripheral smears, bone marrow aspiration and tre-
phine biopsy.
Acute leukemia was the largest group comprising of 128 cases.
Bone marrow aspiration was in agreement with trephine biopsy in
110 cases but was inadequate in 18 cases which had tightly packed
marrow with blasts on biopsy. Aplastic anemia was the next single
largest group with 45 cases. Biopsy in aplastic anemia is of utmost
importance for definitive diagnosis. 6 cases showed diluted/non
diagnostic aspirates which were diagnosed on only trephine biopsy
(Figs. 2 and 3). One case diagnosed in aspiration as hypoplastic
marrow suggestive of aplastic anemia, showed focal increase in
immature precursors and diagnosis was revised to hypoplastic
myelodysplastic syndrome (MDS) in biopsy.
Out of 52 Myeloproliferative neoplasm cases of MPN, 42 cases
were of CML, 2 cases of Essential thrombocythemia (ET), 1 case
of Polycythemia vera (PV), 3 cases of Chronic Eosinophilic Leuke-
mia/Hypereosinophilic syndrome (CEL/HES) and 4 cases were of
Myelofibrosis. Poor aspiration material was found in 9 cases of
CML. Fibrosis was increased in 7 cases. All 4 cases of Myelofibrosis
showed dry tap, trephine showed marked fibrosis and atypical
bizarre megakaryocytes (Fig. 4a–c).
A total 41 cases of lymphoma were analyzed, of which 8 cases
were Hodgkin’s lymphoma, and 33 cases were NHL. Out of 33 cases
of NHL, few cases showed occasional atypical cell in marrow aspi-
rate (but not diagnostic of marrow infiltration by lymphoma). In
BMB, four cases of low grade B cell lymphoma (Fig. 5a and b), 1
case of Follicular lymphoma were detected. One case of Burkitt
lymphoma diagnosed on IHC and unfortunately 02 cases could
not be typed. None of the Hodgkins lymphoma showed marrow
infiltration in aspiration. Among the total, Chronic lymphocytic
leukemia (CLL/SLL) comprised of 16 cases. All cases of CCL/SLL
were diagnosed in BMA. Among 42 cases of multiple myeloma
(plasma cell dyscrasia) 41 cases were detected in BMA. One case
of aspiration showed hypercellular marrow with poor cell trails
showing occasional plasma cells and biopsy was diagnosed to be
of multiple myeloma with marked plasmacytosis. Six cases of
metastasis were encountered in biopsy out of which 2 (33.3%) were
missed in aspiration.
Out of four cases, two cases showed granulomas in both aspira-
tion and biopsy. Whereas two cases showed granulomas in biopsy
only (missed in aspiration). Out of 25 cases of MDS, aspiration and
biopsy correlated in 20 cases, in rest 5 cases, diagnosis was done in
biopsy only. In Immune Thrombocytopenic purpura (ITP), there
were 100% concordance between aspiration and biopsy. Out of 5
cases of Pure Red Cell Aplasia (PRCA), trephine biopsy of one case
showed presence of paratrabecular collection of lymphoid cells
pointing towards the possibility of lymphoma as a probable cause
of PRCA (Secondary PRCA). However, the patient was lost to follow
Table 1
Cases diagnosed in BMA and BMB.
Diagnosis Diagnosis done (Positive) Diagnosis Missed (Negative) Total P value with chi2 test
BM Aspiration 416 88 504 0.0001
BM Biopsy 494 10 504
The chi-square statistic is 68.7673. The p-value is 0.0001. This result is significant at p < 0.05.
<1yrs , 4 
1 -14yrs, 91 
>14yrs, 410 
Fig. 1. Pie chart showing age distribution.
Fig. 2. BMA showing hypocellular marrow, H&E (10  10).
Fig. 3. BMB confirming aplastic anemia H&E (10  10).
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showed extensive necrosis in bone marrow trephine biopsy. The
details are given in Table 2. From the above 2 tests i.e. BMA and
BMB for detection of haematological and non-haematologic disor-
der, it was revealed that 416 cases were diagnosed/positive in both
tests. Hence true positive cases were 416. In the same way, true
negative, false negative and false positive cases were determined
(Table 3). The sensitivity and specificity of the trephine BMB test
were 84% and 90% respectively. The statistical probabilities weredetermined with SPSS 20 software and documented (Tables 3
and 4).4. Discussion
Bone marrow aspiration and biopsy at a single sitting are com-
plementary to each other and therefore should be used together for
diagnosis. Out of total aspirate smears, some cases were inade-
quate for evaluation. According to Bird and Jacobs,8 marked
increase in reticulin in both acute lymphoblastic and acute
myeloblastic leukemia may lead to dry tap. In present study, 3
out of 18 cases of acute leukemia presenting with dry tap showed
increase in fibrosis in trephine sections. So a dry tap or inadequate
aspiration should not be dismissed as a result of faulty technique
but should always be accompanied by trephine biopsy to arrive
at a conclusive diagnosis.
In some cases of acute leukemia, adequate bone marrow aspi-
rate cannot be obtained due to extreme cellularity and compact-
ness of the marrow.8 These are the cases where bone marrow
trephine biopsy has primary diagnostic value. An important limita-
tion of using marrow aspiration alone is mixing of marrow ele-
ments with sinusoidal blood which does not allow accurate
estimation of cellularity.
In lymphomas, cytomorphology combined with immunopheno-
typing, were used for primary diagnostic approach. All cases of Non
Hodgkin’s Lymphoma (NHL) showed evidence of marrow involve-
ment in biopsy. In corresponding aspiration smears only some
smears showed occasional atypical cell, non conclusive of lym-
phoma involving marrow. None of the Hodgkin’s lymphoma
showed infiltration in aspiration. Various studies have reported
marrow infiltration in lymphoma ranging from 27.1 to 55.1%.9,10
In our case all CLL/SLL cases (16) were diagnosed in aspiration
and also in biopsy. In Aplastic anemia, diagnosis was confirmed
only after trephine biopsy, where as some cases were missed in
BMA. Trephine biopsy is the only tool for accurate assessment of
cellularity of the marrow, hence is of utmost importance in diag-
nosing Aplastic anemia.11 In CMPDs, other than Myelofibrosis,
Fig. 4. (a) BMB showing hypocellularity & Fibrosis, H&E (10  10), (b) 40  10, yellow arrow-bizarre megakaryocytes, blue arrow-fibrosis, (c) 10  10 increased reticulin
fibrosis of myelofibrosis.
Fig. 5. (a) 10  10 small cell lymphoma involving marrow, (b) 40  10 I.H.C.-lymphoma involving marrow, CD20 +ve.
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trephine biopsy added information about fibrosis, cellularity and
morphology of megakaryocytes. Also it is of paramount impor-
tance to assess the residual disease. In some cases, the methods
are complementary and thus both are needed, as described by Sab-
harwal et al.12 In Multiple myeloma 41 out of 42 (97.6%) cases of
were diagnosed in bone marrow aspirates alone. One case where
the plasma cells were sparsely scattered in a diluted marrow
showed compact masses of plasma cells in biopsy. Our study cor-
related well with the study done by Pileri et al.13 where they
detected myeloma simultaneously in all bone marrow aspirates
and biopsies. As per Farhi14 plasma cell myeloma, particularly in
cases with low infiltration degree, were more reliably diagnosed
in the biopsy. Granulomas showed higher detection rate in tre-
phine biopsy than aspiration and correlated well with other stud-
ies. No benefits were obtained in cases of erythroid hyperplasia
and reactive marrow. In a study, the BMA alone had a sensitivity
of 86.8% in detecting residual leukemia and of 82.3%, 82.5% and
94.2% for interim, EOI and ‘other marrows’, respectively. Despitethe high concordance between the BMA and the BMTB the poor
sensitivity of the BMA in detecting residual leukemia, particularly
at EOI, may lead to an overestimation of the complete remission
rates which may have therapeutic and clinical trial implications.15
From an Australian study, it was revealed that specificity was
100%; sensitivity 82–91%, positive predictive value 100% and neg-
ative predictive value 90–95%.16 The quantitative assessment of
neuroblastoma cells is recommended to provide data from which
evidence-based numerical criteria for the reporting of bone mar-
row response can be realized. This is particularly important in
the minimal disease setting and when neuroblastoma detection
in bone marrow is intermittent, where clinical impact has yet to
be validated.17–19 Acute leukemias are characterized by neoplastic
proliferation of hematopoietic stem cells and accumulation of
blasts and immature cells in bone marrow. We applied a selective
panel of immunohistochemical markers on bone marrow trephine
tissue sections and observed their utility in diagnosis and typing of
acute leukemia.19 A good bone marrow (BM) sample is essential in
evaluating many haematologic disorders. An unsuccessful BM
Table 2
Number of entities in bone marrow aspiration and bone marrow biopsy.
SL No. Entity BM Aspiration Total % of cases diagnosed
in BMA
BM Biopsy Total % of cases diagnosed
in BMB
Positive Negative Positive Negative
1 Acute Leukemia 110 18 128 21.83 128 0 128 25.40
2 Aplastic Anemia 39 6 45 7.74 44 1 45 8.73
3 Myelo proliferative neoplasm 48 4 52 9.52 52 0 52 10.32
4 Lymphoma* 0 41 41 0.00 41 0 41 8.13
5 Chronic Lympho cytic leukemia 16 0 16 3.17 16 0 16 3.17
6 Multiple myeloma 41 1 42 8.13 42 0 42 8.33
7 Metastasis 4 2 6 0.79 6 0 6 1.19
8 Granuloma 2 2 4 0.40 4 0 4 0.79
9 Myelo dysplastic syndrome 20 5 25 3.97 25 0 25 4.96
10 Immuno thrombocytopenic purpura 32 0 32 6.35 32 0 32 6.35
11 Pure red cell aplasia 5 0 5 0.99 5 0 5 0.99
12 Reactive marrow 30 0 30 5.95 30 0 30 5.95
13 Elytroid hyperplasia 56 0 56 11.11 56 0 56 11.11
14 Necrosis 1 0 1 0.20 1 0 1 0.20
15 Hypersplinism 11 0 11 2.18 11 0 11 2.18
16 Haemophagocytic lympho histocytic syndrom 1 0 1 0.20 1 0 1 0.20
17 Normal bone marrow 0 9 9 0.00 0 9 9 0.00
18 Total 416 88 504 82.54 494 10 504 98.02
Note: Positive-Diagnosis done; Negative-Diagnosis missed; *Lymphoma including CLL/SLL is total 57 (41+16).
Table 3
Statistical probability of BMA and BMB tests.
Statistical probability No. of cases
True Negative (TN) 9
True Positive (TP) 416
False Negative (FN) 78
False Positive (FP) 1
Table 4
Computed probability value of different statistics tests.
Test statistics Formula Value
Sensitivity TP/(TP + FN) 0.84
Specificity TN/(FP + TN) 0.90
Prevalence (TP + FN)/N 0.98
Diagnostic accuracy (TP + TN)/N 0.84
Positive predictivity TP/(TP + FP) 0.99
Negative predictivity TN/(FN + TN) 0.103
False positive rate FP/(FP + TN) 0.1
False negative rate FN/(TP + FN) 157
Positive likelihood ratio Sensitivity/(1  specificity) 8.4
Negative likelihood ratio (1  sensitivity)/specificity 0.177
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immunophenotyping (FCI) in most haematologic malignancies.
Apart from FCI, most ancillary diagnostic techniques in haematol-
ogy are less informative. We describe the feasibility of FCI in
vortex-dislodged cell preparation obtained from unfixed trephine
biopsy (TB) specimens. It reveals efficient procedure which could
be effectively utilized in resource-limited centers and reduce the
frequency of repeat BMA procedures.20,21 Most guidelines suggest
that only the bone marrow aspirate (BMA) is necessary to assess
residual disease following intensive chemotherapy for Acute Mye-
loid Leukemia (AML) with the bone marrow trephine biopsy
(BMTB) recommended in cases of a poor quality BMA.22
However there were some limitations in our study. We could
not analyze the role played by flowcytometers and cytogenetics,
routinely done in this era for all cases of Acute Leukemia and
MDS. Also, lack of use of IHC routinely in cases of NHL due to finan-
cial constraints might have hampered the accuracy of detection of
infiltration.5. Conclusion
Bone marrow trephine biopsy is gold standard and more infor-
mative in assessment of cellularity, pattern, extent of tumor infil-
tration and follow up (especially) of leukemia/lymphomas. It is
an indispensable tool for diagnosis of Aplastic Anemia. However,
it provides less additive information in most Acute Leukemias
and non neoplastic pathologies except for Granulomas. Since, both
procedures can be done in the same sitting, obtaining adequate
biopsy material along with aspirate sample is strongly recom-
mended. In our study, we got high sensitivity and specificity rate
in trephine BMB test. Last, but not the least, interpretation of
biopsy should be carried out not in isolation but keeping in mind
the aspiration findings, as morphology is best assessed in aspira-
tion smears.
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